cagrilintide phase 3 is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had ≥1 weight-related complication, individuals assigned to a combination Dual Therapy CagriSema Promising for

Shortness of breath goes to pulmonology

This study investigates how guselkumab, which targets the IL-23 pathway, may promote transmural healing and modify disease progression

Abbreviated exposure to cuprizone is sufficient to induce demyelination and oligodendrocyte loss

There is currently no antemortem diagnostic test available for PD (Tanner and Goldman 1996), making its diagnosis challenging

Scientists made an unexpected discovery: standard infusion rates cause NAD+ to disappear from plasma faster during the first 2 hours

9 8 Novel and Emerging Treatments Low-Level Laser Therapy Low-level laser therapy, sometimes known as cold laser or photobiomodulation therapy, utilizes wavelengths of light between 660 nm and 905 nm